All News
Filter News
Found 73,707 articles
-
Zymo Research Releases Free Software to Streamline COVID-19 Test Reporting
7/28/2020
Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange.
-
Centene Corporation Reports Second Quarter 2020 Results
7/28/2020
Centene Corporation announced its financial results for the second quarter ended June 30, 2020, reporting diluted earnings per share of $2.05 and Adjusted Diluted EPS of $2.40.
-
CytoSorbents to Report Q2 2020 Operating and Financial Results
7/28/2020
CytoSorbents Corporation, CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q2 2020 financial results after the market close on Tuesday, August 4, 2020.
-
Sobi and Selecta announce closing of previously announced strategic licensing agreement for SEL-212, a phase 3-ready novel treatment for Chronic Refractory Gout
7/28/2020
Swedish Orphan Biovitrum AB announced that the strategic licensing agreement with Selecta Biosciences, Inc. for SEL-212, entered into as earlier announced on June 11, 2020, became effective on July 28, 2020, following the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period.
-
Apogenix to Start European Clinical Phase II Trial with Asunercept in COVID-19 Patients
7/28/2020
Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announced today that it has received regulatory approval to start a clinical phase II trial with asunercept in COVID-19 patients in Russia.
-
LabCorp Announces 2020 Second Quarter Results
7/28/2020
LabCorp announced results for the second quarter ended June 30, 2020.
-
New Study Finds Racial Disparities in COVID-19-related Deaths Exist Beyond Income Differences in 10 Large U.S. Cities
7/28/2020
While data and news reports show that Black and Hispanic communities are disproportionately affected by the 2019 Coronavirus Disease pandemic, the role that neighborhood income plays in COVID-19 deaths is less clear.
-
March of Dimes And The Humana Foundation Partner To Eliminate Health Equity Gap Impacting Moms And Babies Across The U.S.
7/28/2020
March of Dimes, the nation's leader in the fight for the health of all moms and babies, and The Humana Foundation, the philanthropic arm of Humana Inc. are working together to address the racial disparities and social determinants of health that contribute to the U.S. maternal and infant health crisis.
-
c-LEcta Expands Collaboration With Specialty Medical Logistics Provider World Courier
7/28/2020
Cooperation with renowned specialty logistics service provider for the transport of sensitive products
-
BetterLife CEO Discusses Synairgen’s Interferon Breakthrough Treatment
7/28/2020
The Chief Executive Officer for BetterLife Pharma Inc., recently joined investor portal Proactive to discuss the successful trial of another interferon inhalation treatment for COVID-19 similar to BetterLife’s AP-003 product, what this trial means for BetterLife, and what advantages AP-003’s interferon alpha2b may have over interferon beta treatments.
-
Advisory - Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
7/28/2020
Health Canada has authorized with conditions the drug remdesivir manufactured by Gilead Sciences Canada, Inc. for the treatment of patients with severe symptoms of COVID-19 who have pneumonia and require extra oxygen to help them breathe.
-
Reata Announces Initiation of Investigator-Sponsored Study Evaluating Bardoxolone for Complications Associated with COVID-19
7/28/2020
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that researchers at NYU Grossman School of Medicine, led by Sripal Bangalore, MD, interventional cardiologist and professor of Medicine, are initiating an Investigator-Sponsored Trial, known as BARCONA, to study the effect of bardoxolone methyl in patients suffering from COVID-19.
-
Pfizer Reports Second-Quarter 2020 Results
7/28/2020
Pfizer Inc. reported financial results for second-quarter 2020, increased its 2020 financial guidance for revenues and Adjusted diluted EPS and reaffirmed all other components of its 2020 financial guidance, which continues to reflect actual and anticipated business impacts from the novel coronavirus disease of 2019 pandemic.
-
electroCore Announces Non-Invasive Vagus Nerve Stimulation Clinical Update Publication in Cephalalgia
7/28/2020
Paper supports use of nVNS as a front-line therapy for acute and preventative treatment of cluster headache and as an effective option for the treatment of migraine headache
-
Labs Still Do Not Have Supplies for COVID-19 Testing, AACC Survey Finds
7/28/2020
A new survey of U.S. clinical laboratories conducted by AACC has found that nearly half of all responding labs still do not have the supplies they need to run COVID-19 tests.
-
3M Reports Second-Quarter 2020 Results
7/28/2020
Strong Execution and Cash Flow in Uncertain Environment
-
Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China
7/28/2020
Hutchison China MediTech Limited announced that the China National Medical Products Administration has granted Priority Review status to the New Drug Application for savolitinib for the treatment of non-small cell lung cancer with MET Exon 14 skipping mutations.
-
MindMed Completes Dosing 18-MC Phase 1 Study
7/28/2020
Company, seeing early success, will advance preparations for Phase 2a clinical trial in opioid addiction
-
Coronavirus (COVID-19) Update: Daily Roundup - July 28, 2020
7/28/2020
The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic
-
Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China
7/28/2020
Hutchison China MediTech Limited and Eli Lilly and Company announce an amendment to the 2013 License and Collaboration Agreement on Fruquintinib with Lilly Shanghai, an affiliate of Lilly.